Literature DB >> 2932976

Selective removal of heparan sulfate chains from proteoheparan sulfate with a commercial preparation of heparitinase.

M Kato, Y Oike, S Suzuki, K Kimata.   

Abstract

Procedures employing the commercial preparation of heparitinase were developed for isolating a protein-enriched core molecule from proteoheparan sulfate by selective removal of the heparan sulfate chains. Treatment of proteoheparan sulfate with the enzyme preparation caused seriously extensive degradation owing to the presence of proteolytic activity in the enzyme preparation. This effect could be avoided by using a series of protease inhibitors which prevented proteolytic degradation with less significant effect on the heparitinase activity. Application of the procedures to a purified preparation from the Engelbreth-Holm-Swarm tumor yielded a single protein-enriched core fraction with a molecular weight of approximately 450,000, as ascertained by sodium dodceyl sulfate-gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932976     DOI: 10.1016/0003-2697(85)90255-6

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Differential mucin gene expression in human pancreatic and colon cancer cells.

Authors:  S Yonezawa; J C Byrd; R Dahiya; J J Ho; J R Gum; B Griffiths; D M Swallow; Y S Kim
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Sulfated proteoglycans synthesized by Neuro 2a neuroblastoma cells: comparison between cells with and without ganglioside-induced neurites.

Authors:  K Watanabe; A Oohira; R Katoh-Semba; T Totsuka; K Yoshida
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

3.  Purification and N-terminal amino acid sequence of a chondroitin sulphate/dermatan sulphate proteoglycan isolated from intima/media preparations of human aorta.

Authors:  G Stöcker; H E Meyer; C Wagener; H Greiling
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

4.  Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01).

Authors:  D J McQuillan; D M Findlay; A M Hocking; M Yanagishita; R J Midura; V C Hascall
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

5.  Proteoglycan synthesis in human and murine haematopoietic progenitor cell lines: isolation and characterization of a heparan sulphate proteoglycan as a major proteoglycan from the human haematopoietic cell line TF-1.

Authors:  G Stöcker; Z Drzeniek; U Just; W Ostertag; B Siebertz; H Greiling; H D Haubeck
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

6.  Proteoglycan synthesis in haematopoietic cells: isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5.

Authors:  Z Drzeniek; B Siebertz; G Stöcker; U Just; W Ostertag; H Greiling; H D Haubeck
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

7.  Changes in sulfated macromolecules produced in vivo during normal and indomethacin-delayed ulcer healing in rats.

Authors:  K C Lyons; F J Andrews; W D Comper; P E O'Brien
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

8.  Specific stimulation of basal lamina heparan sulfate proteoglycan in mouse uterine epithelium by Matrigel and by transforming growth factor-beta 1.

Authors:  J E Morris; G Gaza; S W Potter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-02       Impact factor: 2.416

9.  Release of cell surface proteoglycans from differentiating colon cells proceeds by cleavage of lipophilic anchor peptides.

Authors:  J A McBain; G C Mueller
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

10.  Glomerular basement membrane proteoglycans are derived from a large precursor.

Authors:  D J Klein; D M Brown; T R Oegema; P E Brenchley; J C Anderson; M A Dickinson; E A Horigan; J R Hassell
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.